<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Lee HG</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Currently, conventional medicine for stroke treatment remains at a standstill. Korean medicine (KM), which is in high demand in Korea, has been shown to have a therapeutic effect on stroke; however, considering the absence of epidemiological and clinical characteristics of patients receiving KM for stroke in Korea and prospective, large-scale, long-term studies on the efficacy and safety of KM, the acquisition of data from KM treatments on stroke is essential.&lt;h4>Objective&lt;/h4>We aimed to collect and analyze data on the major clinical characteristics of patients with stroke receiving KM treatment and investigate the effectiveness and safety of KM in the Korean population.&lt;h4>Methods&lt;/h4>The Registry of Stroke in Korean Medicine Hospital (RoS-KoMH) is a prospective, multi</pubmed_abstract><journal>JMIR research protocols</journal><pagination>e67850</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12690280</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Registry of Stroke in Korean Medicine Hospital (RoS-KoMH): Protocol for a Prospective, Multicenter, Observational Study.</pubmed_title><pmcid>PMC12690280</pmcid><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Kwon S</pubmed_authors><pubmed_authors>Choi DJ</pubmed_authors><pubmed_authors>Kim CH</pubmed_authors><pubmed_authors>Jung WS</pubmed_authors><pubmed_authors>Lee I</pubmed_authors><pubmed_authors>Lee HG</pubmed_authors><pubmed_authors>Moon SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Registry of Stroke in Korean Medicine Hospital (RoS-KoMH): Protocol for a Prospective, Multicenter, Observational Study.</name><description>&lt;h4>Background&lt;/h4>Currently, conventional medicine for stroke treatment remains at a standstill. Korean medicine (KM), which is in high demand in Korea, has been shown to have a therapeutic effect on stroke; however, considering the absence of epidemiological and clinical characteristics of patients receiving KM for stroke in Korea and prospective, large-scale, long-term studies on the efficacy and safety of KM, the acquisition of data from KM treatments on stroke is essential.&lt;h4>Objective&lt;/h4>We aimed to collect and analyze data on the major clinical characteristics of patients with stroke receiving KM treatment and investigate the effectiveness and safety of KM in the Korean population.&lt;h4>Methods&lt;/h4>The Registry of Stroke in Korean Medicine Hospital (RoS-KoMH) is a prospective, multi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-06T00:19:37.822Z</modification><creation>2026-05-23T03:14:09.636Z</creation></dates><accession>S-EPMC12690280</accession><cross_references><pubmed>41289580</pubmed><doi>10.2196/67850</doi></cross_references></HashMap>